Arcutis Biotherapeutics, Inc. (ARQT)

NASDAQ: ARQT · Real-Time Price · USD

24.82

+0.82 (3.42%)

At close: Mar 9, 2026, 4:00 PM EDT

24.70

-0.12 (-0.48%)

After-hours: Mar 9, 2026, 6:20 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
ZORYVE Cream 0.3% Revenue	121.00M	85.08M
ZORYVE Cream 0.3% Revenue Growth	42.21%	191.52%
ZORYVE Foam Revenue	181.89M	71.54M
ZORYVE Foam Revenue Growth	154.26%	-
ZORYVE Cream 0.15% Revenue	68.27M	9.92M
ZORYVE Cream 0.15% Revenue Growth	588.18%	-
ZORYVE Cream 0.05% Revenue	911.00K	-
Total Product Revenue	372.07M	166.54M
Total Product Revenue Growth	123.41%	470.62%
Other Segment Revenue	4.00M	30.00M
Other Segment Revenue Growth	-86.67%	-1.38%
Revenue (Other)	-911.00K	-
Revenue (Total)	376.07M	196.54M
Revenue (Total) Growth	91.34%	229.73%

Updated Feb 25, 2026. Data Source: Fiscal.ai.